Evidence map›Paper›PMID 40959196›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2025

Enhancing Phacoemulsification Safety: How Low Fluidic Settings Influence Active Surge Mitigation Actuation.

Biljana Kuzmanović Elabjer, Tea Štrbac, Iva Ćubela, Mladen Bušić, Mirjana Bjeloš

Abstract read
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Biljana Kuzmanović ElabjerUniversity Eye Department, University Hospital "Sveti Duh", Zagreb, Croatia.ORCID 0000-0002-2751-8067
Tea ŠtrbacUniversity Eye Department, University Hospital "Sveti Duh", Zagreb, Croatia.ORCID 0000-0001-8171-8281
Iva ĆubelaUniversity Eye Department, University Hospital "Sveti Duh", Zagreb, Croatia.
Mladen BušićUniversity Eye Department, University Hospital "Sveti Duh", Zagreb, Croatia.
Mirjana BjelošUniversity Eye Department, University Hospital "Sveti Duh", Zagreb, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Active Surge Mitigation (ASM) is a feature of the Centurion Vision System ACTIVE SENTRY Methods: This retrospective study was conducted at the University Eye Clinic, University Hospital "Sveti Duh" in Zagreb, Croatia, between January 19 and April 12, 2024. Preoperative parameters included age, gender, biometric data from the Zeiss IOL Master 700, and lens hardness, classified according to the Lens Opacities Classification System (LOCS III). The presence of Pseudoexfoliation Syndrome (PEX) and Intraoperative Floppy Iris Syndrome (IFIS) was noted. Intraoperative metrics recorded were total case time, cumulative dissipated energy (CDE), ultrasound time (U/S time), and the number of ASM actuations. Results: ASM actuations were not normally distributed (median = 1; mean = 2.4). Significant positive correlations were identified with age (P = 0.014), lens thickness (P = 0.039), and U/S time (P = 0.015), while no significant differences were observed for anterior chamber depth (ACD), gender, PEX, or IFIS. Logistic regression identified age as a predictor of ASM values ≥1. Conclusion: At low IOP settings, surge events during phacoemulsification are rare. ASM activation is influenced by patient age, lens thickness, and U/S time but not by ACD, gender, PEX, or IFIS. Low IOP fluidics combined with ASM contributes to stable and safe chamber dynamics across diverse patient profiles.

Indexed as

active sentry handpieceASM actuationlow IOP settingssurge events

Identifiers

PMID40959196
PMCPMC12435369

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.